Powered by

Big names from Pfizer, Allergan ride wave of biotech blank-check deals in 2020

Dec 11, 2020 - SNL Financial
Mergers and Acquisitions-Partnership Announcement

With a surge of capital in an uncertain market and very few places to spend it, investors are looking to special purpose acquisition companies to bring biotech companies public in a non-traditional way.

Allergan's former CEO, Brent Saunders, is back in the aesthetics business after Vesper Healthcare Acquisition Corp.'s $975 million purchase of The HydraFacial Co.

Pfizer Inc. and Bain Capital LP's neuroscience spin off Cerevel Therapeutics Holdings Inc. is picked up by ARYA Sciences A...